PT Medela Potentia Tbk’s Subsidiary Showcases Diagnostic Innovations to KONAS & PIT PDS Patklin 2025

PT Medela Potentia Tbk, through its subsidiary PT Djembatan Dua, as part of its ongoing commitment to deliver high-quality innovations in diagnostic medical devices, actively participated in the 12th National Congress (KONAS) and the 24th Annual Scientific Meeting (PIT) of the Indonesian Association of Clinical Pathology and Laboratory Medicine Specialists (PDS Patklin) 2025, held in Medan on October 22–24, 2025.

This participation reaffirmed PT Djembatan Dua’s role as a strategic partner for medical and laboratory professionals in providing diagnostic solutions that are innovative, safe, and aligned with the needs of modern clinical practice.

At its interactive exhibition booth, PT Djembatan Dua showcased a wide range of flagship diagnostic products, including Tubex for typhoid screening, Quidel Triage for cardiac marker testing, DecaBio Glucometer for blood glucose monitoring, as well as various consumable products such as lancets and rapid drug abuse test kits.

In addition, PT Djembatan Dua introduced Vigeo, a single-use needle designed for bone marrow aspiration and biopsy procedures, which enhances laboratory efficiency while ensuring patient safety.

“The product portfolio we present is designed to provide optimal solutions for users—delivering quality, convenience, and safety,” said Mrs. Ariance Margaretha, Business Manager of PT Djembatan Dua.

Mrs. Ariance added that PT Djembatan Dua observed strong enthusiasm from doctors and laboratory professionals, indicating that the innovations introduced can further support high-quality diagnostic practices across Indonesia.

The company’s participation in this event not only served to showcase products but also to strengthen collaborative relationships with medical professionals through various interactive and educational activities, including Tubex troubleshooting sessions and technical discussions on the use of Vigeo, involving both the technical and commercial teams of PT Djembatan Dua.

This approach reflects PT Djembatan Dua’s commitment to being a solution-driven partner—not merely a provider of medical devices, but also an educational collaborator that understands users’ needs in the field.

The PT Djembatan Dua booth attracted significant attention from participants, including members of PDS Patklin, participants of the Specialist Medical Education Program (PPDS), Medical Laboratory Technologists (ATLM), and local distributors. Their enthusiasm reinforced the belief that collaboration among manufacturers, medical professionals, and healthcare institutions is key to building an excellent laboratory services ecosystem in Indonesia.

Through its participation in KONAS XII and PIT XXIV PDS Patklin 2025, PT Djembatan Dua once again underscored its dedication to delivering modern diagnostic solutions that support the advancement of national healthcare quality and uphold global patient safety standards.